EMR
71
-3
PEP
39
-9
SJM
9
-5
D
40
2
MSI
72
-3
BDX
56
10
KLAC
38
-6
MO
60
-2
NOC
41
9
KMX
61
-3
TDC
67
-4
NI
72
4
F
56
-3
R
70
-3
SO
57
6
XEL
67
2
BMY
55
-8
COST
57
-6
SYF
86
-6
PVH
60
-4
EMR
71
-3
PEP
39
-9
SJM
9
-5
D
40
2
MSI
72
-3
BDX
56
10
KLAC
38
-6
MO
60
-2
NOC
41
9
KMX
61
-3
TDC
67
-4
NI
72
4
F
56
-3
R
70
-3
SO
57
6
XEL
67
2
BMY
55
-8
COST
57
-6
SYF
86
-6
PVH
60
-4
Financhill
Back

Avidity Biosciences Quote, Financials, Valuation and Earnings

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.
Sell
28

RNA
Avidity Biosciences

Last Price:
42.16
Seasonality Move:
39.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.

Avidity Biosciences Price Quote

$42.16
-0.02 (-15.63%)
(Updated: November 16, 2024 at 5:36 AM ET)

Avidity Biosciences Key Stats

Sell
28
Avidity Biosciences (RNA) is a Sell
Day range:
$41.84 - $50.32
52-week range:
$5.68 - $56.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
486.02
P/B ratio:
3.97%
Volume:
2M
Avg. volume:
983.4K
1-year change:
577.05%
Market cap:
$6B
Revenue:
$9.6M
EPS:
$-2.89

How Much Does Avidity Biosciences Make?

Is Avidity Biosciences Growing As A Company?

  • What Is Avidity Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.17%
  • What Is Avidity Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Avidity Biosciences Stock Price Performance

What Is Avidity Biosciences 52-Week High & Low?

Avidity Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Avidity Biosciences?

Is Avidity Biosciences Cash Flow Positive?

  • What Is RNA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$184.5M
  • What Is Avidity Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.2B
  • What Is Avidity Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$739M

Avidity Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    RNA return on invested capital is -30.66%
  • What Is Avidity Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -27.28%
  • What Is RNA Return On Equity?
    ROE is a measure of profitability and is -30.66%

Avidity Biosciences Earnings Date & Stock Price

Avidity Biosciences Competitors

  • Who Are Avidity Biosciences's Competitors?
    Below is a list of companies who compete with Avidity Biosciences or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Natera Inc (NTRA)
    • Sarepta Therapeutics Inc (SRPT)
    • Entrada Therapeutics Inc (TRDA)

Avidity Biosciences Dividend Yield

Avidity Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 9.52%
Revenue: -17.1% -48.99%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 67.91
Upside from Last Price: 61%

Major Shareholders

  • How many RNA shares are owned by institutional investors?
    223.6M RNA shares are owned by institutional investors
  • How many RNA shares are owned by insiders?
    700.5K RNA shares are owned by insiders